 Jagran Post |
Rock band Indian Ocean sings for a cause
Jagran Post Pallavi Kumar, executive director, Delhi NCR, for the MOHAN Foundation said: “We organised this event to create awareness about organ donation as sadly in India even if people know about the concept, they don’t know how to go about it. “An individual … |
High-dose vorinostat is effective in relapsed lymphomasOncology Nurse AdvisorThe best responses were seen in those with Hodgkin and diffuse large B-cell lymphomas, which are two of the most aggressive types and typically require a stem cell transplant …
TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG …GlobeNewswire (press release)NEW YORK, Feb. 11, 2013 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (TGTX) today announced that it has amended its Phase I/II study of single agen…
|
Preventive Health check-up – I: Is the Rs5,000 tax deduction enough?
Moneylife PHP is an emotional-sell that began in the West and is now spreading like wildfire among India’s newly affluent with high-paying corporate jobs. The argument that something may be wrong inside your body which you may not know, makes PHP an easy sell. |
|
Using Intra-Articular Corticosteroids (AAEP 2012)
TheHorse.com “The use of corticosteroids in joints involves risk, especially where there is no definitive diagnosis,” Clegg remarked. But with appropriate care and use, veterinarians might be able to mitigate these risks. He urged practitioners to first resolve a … |
|
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial …
PharmiWeb.com (press release) Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular mortality. TRUE-AHF (TRial of Ularitide’s Efficacy and safety in patients with … |
|
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger …
PR Newswire (press release) 11, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development … |
|
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial …
PR Newswire (press release) Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular mortality. TRUE-AHF (TRial of Ularitide’s Efficacy and safety in patients with … |
ITV NewsWelsh Paralympian Backs Organ Donor CampaignITV NewsA shortage of donor organs means that about three people die each month in Wales while waiting for a transplant. Organs that can be donated include hearts, kidneys, livers and lungs. Signing t…
Symposium to discuss new techniques for assessing risk of acute kidney injuryNews-Medical.netLeading critical care experts will discuss new techniques for assessing risk of acute kidney injury (AKI) at an educational symposium to be held at the Eightee…